Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$13.09 - $14.98 $76,772 - $87,857
5,865 Added 27.93%
26,865 $376,000
Q3 2023

Nov 14, 2023

BUY
$12.64 - $14.99 $26,404 - $31,314
2,089 Added 11.05%
21,000 $310,000
Q2 2023

Aug 14, 2023

SELL
$9.85 - $13.17 $7,338 - $9,811
-745 Reduced 3.79%
18,911 $244,000
Q1 2023

May 15, 2023

BUY
$9.44 - $11.88 $51,674 - $65,031
5,474 Added 38.6%
19,656 $193,000
Q4 2022

Feb 14, 2023

SELL
$10.27 - $13.29 $3,584 - $4,638
-349 Reduced 2.4%
14,182 $151,000
Q3 2022

Nov 14, 2022

SELL
$9.93 - $17.44 $87,066 - $152,913
-8,768 Reduced 37.63%
14,531 $152,000
Q2 2022

Aug 15, 2022

SELL
$7.45 - $12.83 $9,148 - $15,755
-1,228 Reduced 5.01%
23,299 $293,000
Q1 2022

May 16, 2022

SELL
$9.75 - $14.44 $4,231 - $6,266
-434 Reduced 1.74%
24,527 $266,000
Q4 2021

Feb 14, 2022

SELL
$13.17 - $20.94 $1,356 - $2,156
-103 Reduced 0.41%
24,961 $351,000
Q3 2021

Nov 15, 2021

SELL
$9.16 - $19.83 $2,729 - $5,909
-298 Reduced 1.17%
25,064 $481,000
Q2 2021

Aug 16, 2021

BUY
$7.25 - $10.99 $74,863 - $113,482
10,326 Added 68.68%
25,362 $250,000
Q1 2021

May 14, 2021

SELL
$4.57 - $11.18 $60,314 - $147,553
-13,198 Reduced 46.75%
15,036 $148,000
Q4 2020

Feb 16, 2021

SELL
$3.73 - $5.6 $7,310 - $10,976
-1,960 Reduced 6.49%
28,234 $126,000
Q3 2020

Nov 16, 2020

SELL
$4.32 - $11.7 $21,142 - $57,259
-4,894 Reduced 13.95%
30,194 $130,000
Q2 2020

Aug 14, 2020

SELL
$2.94 - $9.1 $4,704 - $14,560
-1,600 Reduced 4.36%
35,088 $311,000
Q1 2020

May 15, 2020

SELL
$2.27 - $6.2 $25,678 - $70,134
-11,312 Reduced 23.57%
36,688 $130,000
Q4 2019

Feb 14, 2020

BUY
$3.46 - $6.93 $10,380 - $20,790
3,000 Added 6.67%
48,000 $275,000
Q1 2019

May 15, 2019

BUY
$7.08 - $12.09 $177,000 - $302,250
25,000 Added 125.0%
45,000 $329,000
Q4 2018

Feb 14, 2019

SELL
$8.14 - $13.28 $82,360 - $134,367
-10,118 Reduced 33.59%
20,000 $183,000
Q3 2018

Nov 14, 2018

BUY
$11.85 - $16.0 $22,894 - $30,912
1,932 Added 6.85%
30,118 $373,000
Q2 2018

Aug 14, 2018

BUY
$15.15 - $20.75 $427,017 - $584,859
28,186 New
28,186 $430,000
Q4 2017

Feb 14, 2018

SELL
$17.3 - $24.08 $3.46 Million - $4.82 Million
-200,000 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$15.2 - $21.5 $3.04 Million - $4.3 Million
200,000
200,000 $4.3 Million

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.57B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Weiss Multi Strategy Advisers LLC Portfolio

Follow Weiss Multi Strategy Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.